This journal offers authors two choices to publish their research:
|Articles are freely available to both subscribers and the wider public with permitted reuse.||Articles are made available to subscribers as well as developing countries and patient groups through our access programs.|
|An open access publication fee is payable by authors or their research funder.||No open access publication fee.|
In accordance with Funding Body requirements, Elsevier does offer alternative open access publishing options. Visit http://www.elsevier.com/openaccess for full information.
Your publication choice will have no effect on the peer review process or acceptance of your submission.Details on Open Access Articles:
All articles published open access will be immediately and permanently free for everyone to read and download. We offer authors a choice of user licenses, which define the permitted reuse of articles (see http://www.elsevier.com/openaccesslicenses). We are continuously working with our author communities to select the best choice of license options, currently being defined for this journal as follows:
• Creative Commons Attribution-NonCommercial-NoDerivs (CC BY-NC-ND)
• And if you need to comply with your funding body policy you can apply for the CC BY license after your manuscript is accepted for publication.
To provide open access, this journal has a publication fee which needs to be met by the authors or their research funders for each article published open access.
The open access publication fee for this journal is USD 3000, excluding taxes.There is a 20% discount off the open access publication fee for members of the Alzheimer's Association International Society to Advance Alzheimer's Research and Treatment (ISTAART). Prices are listed below.
|Full Price||Society Member Price*|
|USD 3000||USD 2500|
* To be eligible for the society member discount the corresponding author must be a member of the Alzheimer's Association International Society to Advance Alzheimer's Research and Treatment (ISTAART). To claim the discount the author can verify their membership at article submission stage via EES. Elsevier reserves the right to remove or refuse the discount.Funding Body Agreements
Elsevier has established agreements with funding bodies, including Wellcome Trust and Research Councils UK. This ensures authors can comply with funding body open access policies and may also be reimbursed for their publication fees.
Elsevier supports responsible sharing
Find out how you can share your research published in Elsevier journals.
Authors can share their research in a variety of different ways and Elsevier has a number of green open access options available. We recommend authors see our green open access page for further information. An author can also self-archive their author manuscript immediately and enable public access from their institution's repository after an embargo period. This is the version that has been accepted for publication and which typically includes author-incorporated changes suggested during submission, peer review and in editor-author communications.
For subscription articles, an appropriate amount of time is needed for journals to deliver value to subscribing customers before a manuscript becomes available for free to the public. This is called an embargo period and it begins from the date the article is formally published online in its final and fully citable form (i.e. online publication date).
• Publishing open access with Elsevier
• Funding body agreements
• Open access license policy
• Open access pricing policy